AI assistant
BOTANIX PHARMACEUTICALS LTD — Director's Dealing 2019
Dec 2, 2019
64551_rns_2019-12-02_43cecdf5-c538-4e0d-9bc9-0666d1fb0584.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Botanix Pharmaceuticals Limited ABN 70 009 109 755
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Robert Towner |
|---|---|
| Date of last notice | 1 May 2018 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest. | •Austin 4 Pty Ltd ATF <R&S Towner Super A/C>•Austin 4 Pty Ltd Family Trust <R&S Towner Family A/C>_Relevant interests arise through shareholdings and directorships _ |
| Date of change | 2 December 2019 |
| No. of securities held prior to change | 749,986Ordinary Shares held by Austin 4 Pty Ltd ATF<R&STowner Super A/C>4,053,990 Unlisted Options, exercisable at $0.0675 expiring 1December 2019 and vesting progressively over three years ateach 30 November, subject to continued service to the Company,held by Austin 4 Pty Ltd <R&S Towner Family Account> |
| Class | Ordinary SharesUnlisted Options |
| Number acquired | 4,053,990 Ordinary Shares |
| Number disposed | 4,053,990 Unlisted Options |
| Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation | $0.0675 per Unlisted Options exercised |
| No. of securities held after change | 749,986 | Ordinary Shares held by Austin 4 Pty Ltd ATF<R&S |
|---|---|---|
| Towner Super A/C> | ||
| 4,053,990 | Ordinary Shares held by Austin 4 Pty Ltd <R&S | |
| Towner Family Account> | ||
| Nature of change | Exercise and expiry of Unlisted Options | |
| Example: on-market trade, off-market trade, | ||
| exercise of options, issue of securities under | ||
| dividend reinvestment plan, participation in | ||
| buy-back |
Part 2 – Change of director’s interests in contracts – N/A
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| thispart. | |
|---|---|
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder | N/A |
| (if issued securities) | |
| Date of change | N/A |
| No. and class of securities to which | N/A |
| interest related prior to change | |
| Note: Details are only required for a contract in | |
| relation to which the interest has changed | |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration | N/A |
| Note: If consideration is non-cash, provide details | |
| and an estimated valuation | |
| Interest after change | N/A |
Part 3 –[+] Closed period
| art 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above | No |
| traded during a+closed period where prior written clearance | |
| was required? | |
| If so, was prior written clearance provided to allow the trade to | N/A |
| proceed during this period? | |
| If prior written clearance was provided, on what date was this | N/A |
| provided? |